Ipsilateral Breast Tumor Recurrence with Metachronous Contralateral Axillary Lymph Node Metastasis after Breast-Conserving Surgery with Axillary Lymph Node Dissection
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Contralateral axillary lymph node metastasis (CAM) is classified into synchronous and metachronous CAM. It is considered a stage IV disease by American Joint Community on Cancer (AJCC) cancer staging system. Although ipsilateral breast tumor recurrence (IBTR) with metachronous CAM is rare, it can occur after previous axillary lymph node dissection (ALND) because of altered lymphatic drainage. Metachronous CAM might be a regional disease progression rather than a distant metastasis. Here, we present a case of IBTR with metachronous CAM. This patient was treated with curative intent. The management of CAM remains controversial.
Abstract
Contralateral axillary lymph node metastasis (CAM) is classified into synchronous and metachronous CAM. It is considered a stage IV disease by American Joint Community on Cancer (AJCC) cancer staging system. Although ipsilateral breast tumor recurrence (IBTR) with metachronous CAM is rare, it can occur after previous axillary lymph node dissection (ALND) because of altered lymphatic drainage. Metachronous CAM might be a regional disease progression rather than a distant metastasis. Here, we present a case of IBTR with metachronous CAM. This patient was treated with curative intent. The management of CAM remains controversial.
참고문헌 (11)
- Nieweg OE, "Lymphatics of the breast and the rationale for different injection techniques", Ann Surg Oncol, 8, pp.71S~73S (2001)
- Tokmak H, "Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures", World J Surg Oncol, 12, pp.205~ (2014)
- Maaskant-Braat AJ, "Repeat sentinel node biopsy in patients with locally recurrent breast cancer : a systematic review and meta-analysis of the literature", Breast Cancer Res Treat, 138, pp.13~20 (2013)
- Wang W, "Management of contralateral axillary lymph node metastasis from breast cancer : a clinical dilemma", Tumori, 100, pp.600~604 (2014)
- Moossdorff M, "Contralateral lymph node recurrence in breast cancer : regional event rather than distant metastatic disease. A systematic review of the literature", Eur J Surg Oncol, 41, pp.1128~1136 (2015)
- Chkheidze R, "Isolated contralateral axillary lymph node involvement in breast cancer represents a locally advanced disease not distant metastases", Clin Breast Cancer, 18, pp.298~304 (2018)
- Komoike Y, "Analysis of ipsilateral breast tumor recurrences after breastconserving treatment based on the classification of true recurrences and new primary tumors", Breast Cancer, 12, pp.104~111 (2005)
- Barranger E, "Contralateral axillary sentinel lymph node drainage in breast cancer : a case report", J Surg Oncol, 86, pp.167~169 (2004)
- Lizarraga IM, "Review of risk factors for the development of contralateral breast cancer", Am J Surg, 206, pp.704~708 (2013)
- Morcos B, "Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer", Eur J Surg Oncol, 37, pp.418~421 (2011)
- Aebi S, "Chemotherapy for isolated locoregional recurrence of breast cancer(CALOR) : a randomised trial", Lancet Oncol, 15, pp.156~163 (2014)